Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.16 +0.00 (+0.00%)
As of: Sep 10, 2026 · 3:07 PM EDT

Drugs Made In America Acquisition II Corp. (DMII) Operating Expenses (2025 - 2026)

Drugs Made In America Acquisition's (DMII) quarterly Operating Expenses came in at $112227.0 in Q2 2026, down 52.34% quarter-over-quarter from $235472.0 in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Drugs Made In America Acquisition II Corp. (DMII) Operating Expenses (2025 - 2026) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported Operating Expenses for 2 consecutive years, with $112227.0 the latest figure, recorded in Q2 2026.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 112,227.00
Dec 31, 2025 235,472.00
Sep 30, 2025 155,513.00